Tokio Marine Asset Management CO LTD Amarin Corp Plcuk Transaction History

Tokio Marine Asset Management CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$0.85 - $1.43 $17,425 - $29,315	20,500 Added 18.86%	129,200 $118,000
Q2 2023 Jul 28, 2023	BUY	$1.12 - $1.49 $18,480 - $24,585	16,500 Added 17.9%	108,700 $129,000
Q1 2023 May 11, 2023	SELL	$1.19 - $2.19 $11,543 - $21,243	-9,700 Reduced 9.52%	92,200 $138,000
Q4 2022 Jan 26, 2023	BUY	$1.07 - $1.34 $47,508 - $59,496	44,400 Added 77.22%	101,900 $0
Q3 2022 Nov 10, 2022	SELL	$1.09 - $1.67 $16,132 - $24,716	-14,800 Reduced 20.47%	57,500 $63,000
Q2 2022 Aug 09, 2022	BUY	$1.13 - $3.69 $16,045 - $52,398	14,200 Added 24.44%	72,300 $108,000
Q1 2022 May 13, 2022	BUY	$2.85 - $3.73 $165,585 - $216,713	58,100 New	58,100 $191,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.